GlassScriptPhysician profile
Jules B Lipoff
NPI 1255644365
$258,595.51
in general payments reported to CMS, 2019-2025
7 companies · $4,468 in 2025
The $4,468 reported for 2025 was more than what 89% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,523 · 2024: $252K · 2025: $4,468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $250K · Consulting Fee: $5,643 · Food and Beverage: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $250,305.99 |
| Consulting Fee | $5,642.50 |
| Food and Beverage | $123.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $249,925.99 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $3,990.00 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,480.00 | 2022 | |
| Amgen INC. | $1,652.50 | 2024 | Otezla |
| Novartis Pharmaceuticals Corporation | $452.91 | 2022-2025 | |
| Abbvie INC. | $68.08 | 2024-2025 | |
| Leo Pharma INC. | $26.03 | 2025 | Adbry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jules Lipoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.